Latest Headlines
-
Vivera Announces Launch Of New Testing Software, LabPort
11/23/2021
Vivera is pleased to announce the launch of LabPort, a comprehensive software solution designed to streamline and integrate the diagnostic testing and results reporting process for laboratories, employers, and patients.
-
StageZero Life Sciences ARISTOTLE Multi-Cancer Blood Test Now Available In Greater Toronto Area
11/22/2021
StageZero Life Sciences, Ltd. ("StageZero" or the "Company"), a vertically integrated healthcare company devoted to improving the early detection and management of cancer and other chronic diseases through leading-edge molecular diagnostics and clinical interventions, today announced that people throughout the Greater Toronto Area can now access the company's multi-cancer blood test ARISTOTLE.
-
Applied BioCode Launches 28 New Fungal Analyte Specific Reagents In The US
11/22/2021
Applied BioCode announced today that it has released28 Fungal Analyte Specific Reagents (ASRs) for use in molecular tests. (15 ASRs for mold pathogens, 10 ASRs for yeast pathogens, and 3 ASRs to detect dimorphic fungi).
-
Biocept Launches Combined COVID-19 And Influenza Test To Provide Answers During Peak Flu Season
11/22/2021
Biocept, Inc., a leading provider of molecular diagnostic assays, products, and services, now offers a single test that can detect and distinguish between SARS-CoV-2 and influenza, helping patients and caregivers determine appropriate treatment decisions.
-
PerkinElmer Launches Cloud Based Solution To Enable Remote Lab Management
11/22/2021
PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced the launch of its PKeye Workflow Monitor, a cloud-based platform enabling laboratory personnel to remotely manage and monitor their PerkinElmer instruments and workflows in real-time.
-
PathogenDx Announces Agreement With Axiology Labs To Distribute Its Detectx-Cv Assay Across Africa And Thailand
11/22/2021
PathogenDx, Inc., an Arizona-based technology company which has developed a multiplexed microarray-based pathogen testing platform, today announced a distribution agreement with Axiology Labs, a South African-based laboratory equipment supply company, for its breakthrough Detectx-Cv assay Clade Variant Adaptive Surveillance ("CVAS") technology to identify SARS-CoV-2 variants.
-
Vela Diagnostics Expands Automation Options For SARS-CoV-2 RT-PCR Test
11/19/2021
Vela Diagnostics announced today that the ViroKey® SARS-CoV-2 RT-PCR Test v2.0 that received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA), can now be used with the KingFisher FLEX system and Hamilton Microlab STAR platforms
-
Labcorp To Acquire Toxikon, Expanding Nonclinical Development Testing Capabilities For Pharmaceutical, Biotech And Medical Device Clients
11/18/2021
Labcorp, a leading global life sciences company, today announced that it has entered into a definitive agreement to acquire Toxikon, a contract research organization delivering best-in-class nonclinical testing services.
-
Cardinal Health's WaveMark™ Launches Supply Automation Solution For Clinical Labs
11/18/2021
Cardinal Health today announced its business, WaveMark™ Supply Management and Workflow Solutions, will now be available for implementation in clinical labs across the U.S.
-
Cleveland Clinic Expands Cancer Genomic Testing Capabilities
11/18/2021
In order to better understand a patient’s cancer and identify potential therapeutic targets, Cleveland Clinic now offers an advanced genomic testing platform as standard of care to patients with cancer.